Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Compugen Ltd. (CGEN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.8700-0.0700 (-3.61%)
At close: 04:00PM EDT
1.9400 +0.07 (+3.74%)
After hours: 04:14PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.9400
Open1.9800
Bid1.6800 x 4000
Ask1.9400 x 2900
Day's Range1.8000 - 2.0500
52 Week Range1.6600 - 9.2000
Volume1,113,948
Avg. Volume925,562
Market Cap157.161M
Beta (5Y Monthly)2.39
PE Ratio (TTM)N/A
EPS (TTM)-0.4070
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Compugen Reports First Quarter 2022 Results

    Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today financial results for the first quarter ended March 31, 2022 and provided a corporate update on key events since the start of 2022.

  • Simply Wall St.

    Companies Like Compugen (NASDAQ:CGEN) Are In A Position To Invest In Growth

    We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

  • PR Newswire

    Compugen Announces CFO Departure

    Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that Mr. Ari Krashin, Chief Financial Officer and Chief Operating Officer of Compugen Ltd. (the "Company"), notified the Company of his wish to depart from his position at the Company to pursue other interests. Mr. Krashin will leave in August 2022 and, until his departure, he will continue to support the Company in his current roles. The departure is not r

Advertisement
Advertisement